Literature DB >> 31738938

Synthesis and in vitro cytotoxicity evaluation of star-shaped polymethacrylic conjugates with methotrexate or acitretin as potential antipsoriatic prodrugs.

Anna Mielanczyk1, Katarzyna Mrowiec2, Maria Kupczak3, Łukasz Mielanczyk4, Dorota Scieglinska2, Agnieszka Gogler-Piglowska2, Marek Michalski4, Andrzej Gabriel4, Dorota Neugebauer3, Magdalena Skonieczna5.   

Abstract

Water-soluble polymer-drug conjugates were obtained and analyzed towards their potential use as prodrugs for two hydrophobic antipsoriatic agents, including methotrexate (MTX) and acitretin (AC). The conjugation efficacy of MTX decreased with a decreasing molar ratio of N,N-dimethylaminoethyl methacrylate (DMAEMA) repeating units in the polymethacrylic chains. Cytotoxicity of positively charged (from +5 to +10 mV) nano- and microparticles (3-1500 nm in DMEM at 37 °C) were estimated by in vitro MTT and Annexin-V apoptosis assays on Me45, NHDF, HaCaT and BEAS-2B cell lines. Further, cell cycle analysis revealed arrest in G0/G1 phase in melanoma cells, while neither apoptosis induction nor cell cycle arrest occurred in normal epidermal and epithelial cells. Tested conjugates displayed a novel cytostatic effect in Me45 cells and a pro-apoptotic effect in HaCaT cells. Epithelial BEAS-2B cells were the most sensitive to the tested conjugates and responded via induction of necrosis. Cell line models allowed for characterization of the biologically relevant potential action of pro-drugs. Additionally, a skin in vitro evaluation assay provided the first known evidence of side-effect reduction with pro-drug use. Histological examinations confirmed the lack of negative effects of conjugates on the skin and showed no irritating properties.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acitretin; Antipsoriatic prodrugs; Apoptosis; BEAS-2B cell lines; Cell cycle; HaCaT; In vitro assays: MTT; Me45; Methotrexate; NHDF; Star-shaped polymethacrylic conjugates

Mesh:

Substances:

Year:  2019        PMID: 31738938     DOI: 10.1016/j.ejphar.2019.172804

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Acitretin-Conjugated Dextran Nanoparticles Ameliorate Psoriasis-like Skin Disease at Low Dosages.

Authors:  Jiajia Lan; Yuce Li; Jingjing Wen; Yu Chen; Jing Yang; Liang Zhao; Yuting Xia; Hongyao Du; Juan Tao; Yan Li; Jintao Zhu
Journal:  Front Bioeng Biotechnol       Date:  2022-01-07

2.  Synthesis and Preliminary Anticancer Activity Assessment of N-Glycosides of 2-Amino-1,3,4-thiadiazoles.

Authors:  Katarzyna Żurawska; Marcin Stokowy; Patryk Kapica; Monika Olesiejuk; Agnieszka Kudelko; Katarzyna Papaj; Magdalena Skonieczna; Wiesław Szeja; Krzysztof Walczak; Anna Kasprzycka
Journal:  Molecules       Date:  2021-11-29       Impact factor: 4.411

3.  Microneedle Patch Delivery of Methotrexate-Loaded Albumin Nanoparticles to Immune Cells Achieves a Potent Antipsoriatic Effect.

Authors:  Huaiji Wang; Zihan Zhao; Chenghao Wu; Xiaowen Tong; Yuling Shi; Shunjie Chen
Journal:  Int J Nanomedicine       Date:  2022-09-01

4.  Tri- and Pentacyclic Azaphenothiazine as Pro-Apoptotic Agents in Lung Carcinoma with a Protective Potential to Healthy Cell Lines.

Authors:  Magdalena Skonieczna; Anna Kasprzycka; Małgorzata Jeleń; Beata Morak-Młodawska
Journal:  Molecules       Date:  2022-08-17       Impact factor: 4.927

5.  Effect of Ducrosia flabellifolia and Savignya parviflora Extracts on Inhibition of Human Colon and Prostate Cancer Cell Lines.

Authors:  Youssef Saeed Alghamdi; Osama Moseilhy Saleh; Nada Alqadri; Mutaib Mosaued Mashraqi; Omar Bahattab; Nabil Saied Awad
Journal:  Curr Issues Mol Biol       Date:  2021-10-10       Impact factor: 2.976

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.